Allstate Corporation’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,589
| Closed | -$628K | – | 218 |
|
|
2025
Q1 | $628K | Buy |
4,589
+291
| +7% | +$39.8K | 0.02% | 461 |
|
|
2024
Q4 | $657K | Buy |
+4,298
| New | +$657K | 0.02% | 408 |
|
|
2023
Q1 | – | Sell |
-5,784
| Closed | -$1.6M | – | 239 |
|
|
2022
Q4 | $1.6M | Buy |
5,784
+2,639
| +84% | +$731K | 0.05% | 240 |
|
|
2022
Q3 | $840K | Sell |
3,145
-2,674
| -46% | -$714K | 0.02% | 381 |
|
|
2022
Q2 | $1.19M | Sell |
5,819
-1,749
| -23% | -$357K | 0.04% | 294 |
|
|
2022
Q1 | $1.59M | Buy |
7,568
+5,186
| +218% | +$1.09M | 0.04% | 303 |
|
|
2021
Q4 | $571K | Sell |
2,382
-396
| -14% | -$94.9K | 0.01% | 658 |
|
|
2021
Q3 | $786K | Sell |
2,778
-117
| -4% | -$33.1K | 0.03% | 363 |
|
|
2021
Q2 | $1M | Buy |
2,895
+36
| +1% | +$12.5K | 0.03% | 304 |
|
|
2021
Q1 | $800K | Buy |
2,859
+317
| +12% | +$88.7K | 0.03% | 377 |
|
|
2020
Q4 | $622K | Sell |
2,542
-45
| -2% | -$11K | 0.02% | 409 |
|
|
2020
Q3 | $734K | Sell |
2,587
-2,090
| -45% | -$593K | 0.02% | 310 |
|
|
2020
Q2 | $1.25M | Sell |
4,677
-726
| -13% | -$194K | 0.04% | 201 |
|
|
2020
Q1 | $1.71M | Sell |
5,403
-11,496
| -68% | -$3.64M | 0.07% | 136 |
|
|
2019
Q4 | $5.01M | Buy |
16,899
+1,212
| +8% | +$360K | 0.09% | 139 |
|
|
2019
Q3 | $3.65M | Buy |
15,687
+1,135
| +8% | +$264K | 0.06% | 185 |
|
|
2019
Q2 | $3.4M | Sell |
14,552
-1,266
| -8% | -$296K | 0.06% | 179 |
|
|
2019
Q1 | $3.74M | Buy |
15,818
+407
| +3% | +$96.2K | 0.1% | 142 |
|
|
2018
Q4 | $4.64M | Buy |
+15,411
| New | +$4.64M | 0.15% | 97 |
|
|
2017
Q3 | – | Sell |
-7,878
| Closed | -$2.14M | – | 59 |
|
|
2017
Q2 | $2.14M | Hold |
7,878
| – | – | 0.11% | 77 |
|
|
2017
Q1 | $2.15M | Sell |
7,878
-9,407
| -54% | -$2.57M | 0.13% | 118 |
|
|
2016
Q4 | $4.9M | Buy |
+17,285
| New | +$4.9M | 0.29% | 107 |
|